ALTERITY THERAPEUTICS LIMITED - AMERICAN DEPOSITAR
1.2000
14-November-24 09:57:42
15 minutes delayed
Stocks
+0.0200
+1.69%
Today's range
1.2000 - 1.2900
ISIN
N/A
Source
NASDAQ
-
12 Nov 2024 06:35:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434
06 Nov 2024 06:35:00 By Nasdaq GlobeNewswire
-
Appendix 4C – Q1 FY25 Quarterly Cash Flow Report
31 Oct 2024 06:35:00 By Nasdaq GlobeNewswire
-
14 Oct 2024 06:35:00 By Nasdaq GlobeNewswire
-
11 Oct 2024 06:35:00 By Nasdaq GlobeNewswire
-
02 Oct 2024 06:35:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
30 Sep 2024 06:35:00 By Nasdaq GlobeNewswire
-
23 Sep 2024 06:35:00 By Nasdaq GlobeNewswire
-
Appendix 4C – Q4 FY24 Quarterly Cash Flow Report
31 Jul 2024 06:35:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics to Present at MST Financial Webinar
24 Jul 2024 06:35:00 By Nasdaq GlobeNewswire
-
17 Jul 2024 06:35:00 By Nasdaq GlobeNewswire
-
17 Jul 2024 06:25:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar
12 Jun 2024 18:22:16 By Nasdaq GlobeNewswire
-
Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study
29 May 2024 18:21:24 By Nasdaq GlobeNewswire
-
08 May 2024 06:25:00 By Nasdaq GlobeNewswire
-
Appendix 4C – Q3 FY24 Quarterly Cash Flow Report
30 Apr 2024 06:25:00 By Nasdaq GlobeNewswire
-
29 Apr 2024 06:25:00 By Nasdaq GlobeNewswire
-
17 Apr 2024 06:25:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
10 Apr 2024 06:25:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
26 Mar 2024 09:25:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >